Bio Rad Laboratories earnings were -$675.9M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest BIO earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$341.9M, down 207.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BIO reported annual earnings of -$1.8B, with 189.4% growth.
Bio Rad Laboratories Earnings Reports & History FAQ
What were Bio Rad Laboratories's earnings last quarter?
On BIO's earnings call on Invalid Date, Bio Rad Laboratories (NYSE: BIO) reported Q3 2025 earnings per share (EPS) of -$12.70, up 154.34% year over year. Total BIO earnings for the quarter were -$341.90 million. In the same quarter last year, Bio Rad Laboratories's earnings per share (EPS) was $23.37.
Is Bio Rad Laboratories profitable or losing money?
As of the last Bio Rad Laboratories earnings report, Bio Rad Laboratories is currently losing money. Bio Rad Laboratories's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$675.90 million, a 13.2% decrease year over year.
What was BIO's earnings growth in the past year?
As of Bio Rad Laboratories's earnings date in Invalid Date, Bio Rad Laboratories's earnings has grown year over year. BIO earnings in the past year totalled -$675.90 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.